Platinum Investment Management LTD Bluebird Bio, Inc. Transaction History

Platinum Investment Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$16.59 - $33.89 $8.89 Million - $18.2 Million	-535,573 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $764,197 - $1.05 Million	27,789 Added 5.47%	535,573 $23.2 Million
Q2 2020 Aug 06, 2020	BUY	$27.12 - $45.97 $1.49 Million - $2.52 Million	54,844 Added 12.11%	507,784 $31 Million
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $11.8 Million - $28.8 Million	452,940 New	452,940 $20.8 Million

42.6M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $466M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.